SUTRO BIOPHARMA, INC. Quarterly Marketable Securities, Current in USD from Q3 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Sutro Biopharma, Inc. quarterly Marketable Securities, Current history and growth rate from Q3 2018 to Q2 2024.
  • Sutro Biopharma, Inc. Marketable Securities, Current for the quarter ending June 30, 2024 was $285M, a 131% increase year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $285M +$162M +131% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $202M +$13.4M +7.09% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $264M +$9.32M +3.66% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 $239M +$48.7M +25.6% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $123M +$10.7M +9.5% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $189M +$46.5M +32.6% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $255M +$125M +95.7% Dec 31, 2022 10-K 2024-03-25
Q3 2022 $191M +$31.3M +19.7% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $113M -$54.5M -32.6% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $143M -$22M -13.4% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $130M +$10M +8.31% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $159M +$21.2M +15.4% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $167M +$31M +22.8% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $164M +$92.6M +129% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $120M +$7.44M +6.59% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $138M +$24.8M +21.9% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $136M +$2.24M +1.68% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $71.8M -$72.1M -50.1% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $113M +$33.7M +42.6% Dec 31, 2019 10-K 2021-03-18
Q3 2019 $113M +$31.6M +38.7% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $134M Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $144M Mar 31, 2019 10-Q 2019-05-15
Q4 2018 $79.2M Dec 31, 2018 10-K 2020-03-16
Q3 2018 $81.6M Sep 30, 2018 10-Q 2018-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.